Material heterogeneity, microstructure, and microcracks demonstrate differential influence on crack initiation and propagation in cortical bone
- 28 May 2018
- journal article
- research article
- Published by Springer Nature in Biomechanics and Modeling in Mechanobiology
- Vol. 17 (5) , 1415-1428
Abstract
The recent studies have shown that long-term bisphosphonate use may result in a number of mechanical alterations in the bone tissue including a reduction in compositional heterogeneity and an increase in microcrack density. There are limited number of experimental and computational studies in the literature that evaluated how these modifications affect crack initiation and propagation in cortical bone. Therefore, in this study, the entire crack growth process including initiation and propagation was simulated at the microscale by using the cohesive extended finite element method. Models with homogeneous and heterogeneous material properties (represented at the microscale capturing the variability in material property values and their distribution) as well as different microcrack density and microstructure were compared. The results showed that initiation fracture resistance was higher in models with homogeneous material properties compared to heterogeneous ones, whereas an opposite trend was observed in propagation fracture resistance. The increase in material heterogeneity level up to 10 different material property sets increased the propagation fracture resistance beyond which a decrease was observed while still remaining higher than the homogeneous material distribution. The simulation results also showed that the total osteonal area influenced crack propagation and the local osteonal area near the initial crack affected the crack initiation behavior. In addition, the initiation fracture resistance was higher in models representing bisphosphonate treated bone (low material heterogeneity, high microcrack density) compared to untreated bone models (high material heterogeneity, low microcrack density), whereas an opposite trend was observed at later stages of crack growth. In summary, the results demonstrated that tissue material heterogeneity, microstructure, and microcrack density influenced crack initiation and propagation differently. The findings also elucidate how possible modifications in material heterogeneity and microcrack density due to bisphosphonate treatment may influence the initiation and propagation fracture resistance of cortical bone.Keywords
Funding Information
- Division of Civil, Mechanical and Manufacturing Innovation (CMMI-1434412)
- XSEDE (MSS-160001)
This publication has 59 references indexed in Scilit:
- Proposed pathogenesis for atypical femoral fractures: Lessons from materials researchBone, 2013
- Fourier transform infrared imaging of femoral neck bone: Reduced heterogeneity of mineral-to-matrix and carbonate-to-phosphate and more variable crystallinity in treatment-naive fracture cases compared with fracture-free controlsJournal of Bone and Mineral Research, 2012
- Mechanical property and tissue mineral density differences among severely suppressed bone turnover (SSBT) patients, osteoporotic patients, and normal subjectsBone, 2011
- Spectroscopic markers of bone quality in alendronate-treated postmenopausal womenOsteoporosis International, 2008
- Alendronate Reduces Bone Toughness of Ribs without Significantly Increasing Microdamage Accumulation in Dogs Following 3 Years of Daily TreatmentCalcified Tissue International, 2008
- Microcrack Frequency and Bone Remodeling in Postmenopausal Osteoporotic Women on Long-Term Bisphosphonates: A Bone Biopsy StudyJournal of Bone and Mineral Research, 2007
- Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosisBone, 2007
- Extended finite element method for cohesive crack growthEngineering Fracture Mechanics, 2002
- Intermittent and Continuous Administration of the Bisphosphonate Ibandronate in Ovariohysterectomized Beagle Dogs: Effects on Bone Morphometry and Mineral PropertiesJournal of Bone and Mineral Research, 1999
- Risedronate treatment does not increase microdamage in the canine femoral neckBone, 1995